2016 ACR适宜性标准:乳腺癌筛查

2016-11-01 美国放射学会 J Am Coll Radiol. 2016 Nov;13(11S):R45-R49.

本文主要介绍了以上3种检查方法以及其他影像学检查方法在乳腺癌筛查中的应用。

中文标题:

2016 ACR适宜性标准:乳腺癌筛查

英文标题:

ACR Appropriateness Criteria Breast Cancer Screening.

发布机构:

美国放射学会

发布日期:

2016-11-01

简要介绍:

乳腺钼靶检查是一般女性人群乳腺癌建议的筛查方法,针对高风险人群的筛查建议采用MRI和超声检查作为补充检查技术。本文主要介绍了以上3种检查方法以及其他影像学检查方法在乳腺癌筛查中的应用。 拓展指南:乳腺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 ACR适宜性标准:乳腺癌筛查)] GetToolGuiderByIdResponse(projectId=1, id=6e2ff1c001336996, title=2016 ACR适宜性标准:乳腺癌筛查, enTitle=ACR Appropriateness Criteria Breast Cancer Screening., guiderFrom=J Am Coll Radiol. 2016 Nov;13(11S):R45-R49., authorId=null, author=, summary=本文主要介绍了以上3种检查方法以及其他影像学检查方法在乳腺癌筛查中的应用。, cover=, journalId=null, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会(American College of Radiology)拥有会员超过34,000名,包括美国放射医师,放射肿瘤学家,物理学家介入医师及核医学医师。其指南按放射检查的方法分类,共十组,每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Tue Nov 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=乳腺钼靶检查是一般女性人群乳腺癌建议的筛查方法,针对高风险人群的筛查建议采用MRI和超声检查作为补充检查技术。本文主要介绍了以上3种检查方法以及其他影像学检查方法在乳腺癌筛查中的应用。 拓展指南:<strong>与<font color=red>乳腺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6283e1c00133a52c" title="2016 NCCN临床实践指南:乳腺癌-证据块(2016.V2)" target=_blank>2016 NCCN临床实践指南:乳腺癌-证据块(2016.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7bcae1c00133039c" title="2016 ACR适宜性标准:Ⅰ期乳腺癌" target=_blank>2016 ACR适宜性标准:Ⅰ期乳腺癌</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=42c8e1c00132a4b7" title="2016 EMAS立场声明:乳腺癌患者骨质疏松的管理" target=_blank>2016 EMAS立场声明:乳腺癌患者骨质疏松的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d32a01c0013191ca" title="2016 ACOG委员会意见:雌激素依赖性乳腺癌病史女性阴道雌激素的应用(No.659)" target=_blank>2016 ACOG委员会意见:雌激素依赖性乳腺癌病史女性阴道雌激素的应用(No.659)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=09d821c001310115" title="2016 中国早期乳腺癌卵巢功能抑制临床应用专家共识" target=_blank>2016 中国早期乳腺癌卵巢功能抑制临床应用专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B9%B3%E8%85%BA%E7%99%8C" target=_blank>有关乳腺癌更多指南</a></ul>, tagList=[TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4695, appHits=176, showAppHits=0, pcHits=3377, showPcHits=1561, likes=188, shares=9, comments=2, approvalStatus=1, publishedTime=Tue Nov 29 14:17:53 CST 2016, publishedTimeString=2016-11-01, pcVisible=1, appVisible=1, editorId=5295955, editor=yingzheng.gu, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yingzheng.gu, createdTime=Tue Nov 29 14:17:53 CST 2016, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 03:46:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ACR适宜性标准:乳腺癌筛查)])
2016 ACR适宜性标准:乳腺癌筛查
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=164450, encodeId=9ee7164450ef, content=早筛查, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8ujyPAHRD5Glia7aGv7gkTEciaQQD8GLNicXdoiaUlc9icDTTh1CjXXHOqDTAaRY2XBL5AWqiajZT3hZc/0, createdBy=60c11997124, createdName=1e1bb725m44(暂无匿称), createdTime=Tue Dec 20 18:41:59 CST 2016, time=2016-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=158893, encodeId=c37e158893d9, content=乳腺癌筛查是必须的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Nov 29 14:57:33 CST 2016, time=2016-11-29, status=1, ipAttribution=)]
    2016-12-20 1e1bb725m44(暂无匿称)

    早筛查

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=164450, encodeId=9ee7164450ef, content=早筛查, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8ujyPAHRD5Glia7aGv7gkTEciaQQD8GLNicXdoiaUlc9icDTTh1CjXXHOqDTAaRY2XBL5AWqiajZT3hZc/0, createdBy=60c11997124, createdName=1e1bb725m44(暂无匿称), createdTime=Tue Dec 20 18:41:59 CST 2016, time=2016-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=158893, encodeId=c37e158893d9, content=乳腺癌筛查是必须的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Tue Nov 29 14:57:33 CST 2016, time=2016-11-29, status=1, ipAttribution=)]
    2016-11-29 1e160a78m83(暂无匿称)

    乳腺癌筛查是必须的

    0